Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
May 23, 2018 - Sun Pharma announced the FDA approval of Yonsa (abiraterone), for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) in combination with methylprednisolone.
Return to publications